6.65
price up icon1.37%   0.09
after-market Handel nachbörslich: 6.64 -0.01 -0.15%
loading
Schlusskurs vom Vortag:
$6.56
Offen:
$6.58
24-Stunden-Volumen:
4.27M
Relative Volume:
1.60
Marktkapitalisierung:
$1.06B
Einnahmen:
$418.84M
Nettoeinkommen (Verlust:
$-1.60M
KGV:
-645.63
EPS:
-0.0103
Netto-Cashflow:
$69.77M
1W Leistung:
-5.81%
1M Leistung:
+0.45%
6M Leistung:
-41.05%
1J Leistung:
-36.24%
1-Tages-Spanne:
Value
$6.445
$6.715
1-Wochen-Bereich:
Value
$6.31
$7.21
52-Wochen-Spanne:
Value
$6.04
$15.38

Certara Inc Stock (CERT) Company Profile

Name
Firmenname
Certara Inc
Name
Telefon
(415) 237-8272
Name
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Name
Mitarbeiter
1,576
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
CERT's Discussions on Twitter

Compare CERT vs VEEV, TEM, BTSG, HQY, WAY

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
CERT
Certara Inc
6.65 1.06B 418.84M -1.60M 69.77M -0.0103
Health Information Services icon
VEEV
Veeva Systems Inc
178.88 29.40B 3.20B 908.91M 1.42B 5.4155
Health Information Services icon
TEM
Tempus Ai Inc
49.98 8.94B 1.27B -245.03M -245.36M -1.4071
Health Information Services icon
BTSG
Brightspring Health Services Inc
38.31 7.36B 12.91B 104.80M 394.69M 0.8769
Health Information Services icon
HQY
Healthequity Inc
77.81 6.65B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
24.16 4.63B 1.10B 112.09M 283.19M 0.6096

Certara Inc Stock (CERT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-03-06 Herabstufung Barclays Overweight → Equal Weight
2026-02-27 Herabstufung Craig Hallum Buy → Hold
2026-01-06 Hochstufung Leerink Partners Market Perform → Outperform
2025-11-21 Eingeleitet Rothschild & Co Redburn Buy
2025-11-13 Eingeleitet BMO Capital Markets Market Perform
2025-09-29 Eingeleitet Craig Hallum Buy
2025-07-03 Fortgesetzt Morgan Stanley Equal-Weight
2025-05-08 Hochstufung Barclays Equal Weight → Overweight
2025-02-27 Eingeleitet TD Cowen Buy
2024-09-27 Hochstufung UBS Neutral → Buy
2024-04-10 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2024-04-04 Eingeleitet JMP Securities Mkt Perform
2024-02-26 Eingeleitet Leerink Partners Market Perform
2023-12-07 Eingeleitet UBS Neutral
2023-12-05 Eingeleitet KeyBanc Capital Markets Sector Weight
2023-08-22 Herabstufung Jefferies Buy → Hold
2023-08-10 Herabstufung William Blair Outperform → Mkt Perform
2023-04-12 Eingeleitet Stephens Overweight
2023-04-03 Herabstufung Barclays Overweight → Equal Weight
2022-12-14 Herabstufung Robert W. Baird Outperform → Neutral
2022-09-08 Eingeleitet Berenberg Buy
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-07-01 Eingeleitet Piper Sandler Overweight
2022-01-11 Hochstufung Jefferies Hold → Buy
2021-08-05 Fortgesetzt Credit Suisse Neutral
2021-07-23 Eingeleitet Robert W. Baird Outperform
2021-03-03 Eingeleitet Barclays Overweight
2021-01-06 Eingeleitet Morgan Stanley Equal-Weight
2021-01-05 Eingeleitet BofA Securities Buy
2021-01-05 Eingeleitet Credit Suisse Neutral
2021-01-05 Eingeleitet Jefferies Hold
2021-01-05 Eingeleitet William Blair Outperform
Alle ansehen

Certara Inc Aktie (CERT) Neueste Nachrichten

pulisher
Mar 15, 2026

Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches - simplywall.st

Mar 15, 2026
pulisher
Mar 15, 2026

Certara, Inc. $CERT is ArrowMark Colorado Holdings LLC's 5th Largest Position - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Is Certara (CERT) Offering Opportunity After Prolonged Share Price Weakness - Yahoo Finance

Mar 15, 2026
pulisher
Mar 14, 2026

Topline Capital Management LLC Purchases Shares of 546,471 Certara, Inc. $CERT - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Brown Brothers Harriman & Co. Has $46 Million Holdings in Certara, Inc. $CERT - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Alpha Wave Global LP Takes Position in Certara, Inc. $CERT - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip - Yahoo Finance

Mar 14, 2026
pulisher
Mar 13, 2026

Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds - Yahoo Finance

Mar 13, 2026
pulisher
Mar 12, 2026

Certara (CERT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 12, 2026
pulisher
Mar 12, 2026

Avoiding Lag: Real-Time Signals in (CERT) Movement - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 10, 2026

Certara at Barclays Healthcare Conference: Strategic Growth and AI Integration - Investing.com

Mar 10, 2026
pulisher
Mar 10, 2026

Dixon Mitchell Investment Counsel Inc. Purchases Shares of 866,380 Certara, Inc. $CERT - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

Certara at Leerink Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com India

Mar 09, 2026
pulisher
Mar 09, 2026

Certara at Leerink Conference: Strategic Moves Amid Challenges - Investing.com

Mar 09, 2026
pulisher
Mar 09, 2026

Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

How Investors Are Reacting To Certara (CERT) FDA Acceptance Of Simcyp In Place Of Clinical Trials - Sahm

Mar 09, 2026
pulisher
Mar 08, 2026

Assessing Certara (CERT) Valuation After FDA PBPK Milestone And Latest Earnings Guidance - Sahm

Mar 08, 2026
pulisher
Mar 07, 2026

Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference - Yahoo Finance

Mar 07, 2026
pulisher
Mar 07, 2026

Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook - MSN

Mar 07, 2026
pulisher
Mar 07, 2026

Earnings estimates moving higher for Certara (CERT): Time to buy? - MSN

Mar 07, 2026
pulisher
Mar 07, 2026

Will Certara Inc. stock outperform international peers2025 EndofYear Setup & Short-Term Trading Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

CERTCertara Inc Stock Price and Quote - Finviz

Mar 06, 2026
pulisher
Mar 06, 2026

Certara, Inc. (CERT): Analysts Assign Equal-Weight Rating Amid Price Stagnation - 富途牛牛

Mar 06, 2026
pulisher
Mar 06, 2026

Certara (CERT) Downgraded to Equal-Weight by Barclays | CERT Sto - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Certara's (CERT) Equal Weight Rating Reiterated at Barclays - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Forecasting The Future: 7 Analyst Projections For Certara - Benzinga

Mar 06, 2026
pulisher
Mar 06, 2026

Barclays downgrades Certara stock rating on turnaround concerns By Investing.com - Investing.com South Africa

Mar 06, 2026
pulisher
Mar 06, 2026

Barclays downgrades Certara stock rating on turnaround concerns - Investing.com

Mar 06, 2026
pulisher
Mar 03, 2026

Certara at TD Cowen Conference: Strategic Focus and AI Integration By Investing.com - Investing.com Canada

Mar 03, 2026
pulisher
Mar 03, 2026

Certara at TD Cowen Conference: Strategic Focus and AI Integration - Investing.com UK

Mar 03, 2026
pulisher
Mar 03, 2026

Certara (CERT) Gains FDA Acceptance for PBPK Modeling in Drug Ap - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Certara, Inc. (CERT) Stock Analysis: Exploring a 38% Potential Upside in Health Information Services - DirectorsTalk Interviews

Mar 03, 2026
pulisher
Mar 03, 2026

CERT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Certara Simcyp® simulator results replace ten human trials for chronic myeloid leukemia (CML) therapy asciminib - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - Bitget

Mar 03, 2026
pulisher
Mar 03, 2026

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - The Manila Times

Mar 03, 2026
pulisher
Mar 03, 2026

FDA accepts virtual-patient data so leukemia drug avoids 10 trials - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Certara, Inc. $CERT Stock Holdings Boosted by Roubaix Capital LLC - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

Certara Earnings Call: Software Strength Amid Transition - The Globe and Mail

Mar 02, 2026
pulisher
Mar 02, 2026

Certara (CERT) director granted 5,547 restricted stock units - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Certara (CERT) director Arjun Bedi submits initial Form 3 insider filing - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

Certara (CERT) Is Up 9.6% After Calling 2026 a Transition Year With Slower Growth Guidance - simplywall.st

Mar 01, 2026
pulisher
Mar 01, 2026

Assessing Certara (CERT) Valuation After Recent Share Price Volatility - Yahoo Finance

Mar 01, 2026
pulisher
Feb 28, 2026

Discipline and Rules-Based Execution in CERT Response - Stock Traders Daily

Feb 28, 2026
pulisher
Feb 28, 2026

A Look At Certara (CERT) Valuation After Earnings Miss And 2026 Outlook Reset - simplywall.st

Feb 28, 2026
pulisher
Feb 28, 2026

Certara, Inc. Hits 52-Week Low at USD 6.04 Amid Market Struggles - Markets Mojo

Feb 28, 2026
pulisher
Feb 27, 2026

Certara (NASDAQ:CERT) Trading 6.1% HigherHere's What Happened - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Certara (CERT) Target Price Lowered by Barclays to $8.00 | CERT Stock News - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Certara (NASDAQ:CERT) Given New $8.00 Price Target at Barclays - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Certara stock downgraded at Craig-Hallum on growth concerns By Investing.com - Investing.com Canada

Feb 27, 2026
pulisher
Feb 27, 2026

Certara stock downgraded at Craig-Hallum on growth concerns - Investing.com

Feb 27, 2026

Finanzdaten der Certara Inc-Aktie (CERT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
health_information_services TXG
$18.79
price down icon 0.79%
$21.68
price down icon 0.23%
$45.00
price up icon 1.21%
$15.76
price down icon 4.66%
$24.37
price up icon 0.37%
health_information_services WAY
$24.16
price down icon 1.83%
Kapitalisierung:     |  Volumen (24h):